Valuation: Curiosis, Inc.

Market Cap 12TCr 8.9Cr 7.67Cr 7.26Cr 6.58Cr 12Cr 850.49Cr 12Cr 86Cr 33Cr 432.69Cr 33Cr 33Cr 1.37TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 10Cr 75.3T 64.88T 61.43T 55.68T 1L 71.93L 1L 7L 3L 36.6L 3L 3L 1.16Cr EV / Sales 2026 *
6.55x
EV / Sales 2027 * 4.22x
Free-Float
85.65%
Yield 2026 *
-
Yield 2027 * -
1 day-6.12%
1 week-8.75%
Current month-14.25%
1 month-34.18%
3 months-42.71%
6 months-77.33%
Current year-68.08%
1 week 7,720
Extreme 7720
8,790
1 month 7,720
Extreme 7720
11,710
Current year 7,720
Extreme 7720
44,000
1 year 7,720
Extreme 7720
48,200
3 years 7,720
Extreme 7720
48,200
5 years 7,720
Extreme 7720
48,200
10 years 7,720
Extreme 7720
48,200
Manager TitleAgeSince
Chief Executive Officer 55 01/01/2015
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 01/01/2015
Director/Board Member 57 01/12/2016
Director/Board Member 56 01/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
-6.12%-8.75% - - 9.48Cr
-0.07%+0.91%+28.25%+18.01% 23TCr
+0.45%-2.20%+6.45%-20.82% 14TCr
+1.36%+6.78%-13.85%+23.10% 13TCr
+4.13%-0.26%-55.08%-15.22% 6.23TCr
+1.99%+0.96%-18.45%-13.93% 4.94TCr
+1.27%-1.21%+12.65%+15.74% 4.86TCr
-0.96%-0.84%+15.90%+26.75% 4.14TCr
-1.28%+0.25%+35.07%+48.49% 4.01TCr
+1.91%+0.56%-18.03%+50.56% 3.12TCr
Average +0.25%-3.44%-0.79%+14.74% 7.7TCr
Weighted average by Cap. +0.74%-2.40%+4.22%+10.27%

Financials

2026 *2027 *
Net sales 1.54TCr 1.15Cr 98.99L 93.73L 84.95L 1.59Cr 109.76Cr 1.6Cr 11Cr 4.28Cr 56Cr 4.31Cr 4.22Cr 176.45Cr 2.39TCr 1.78Cr 1.54Cr 1.45Cr 1.32Cr 2.47Cr 170.34Cr 2.49Cr 17Cr 6.64Cr 87Cr 6.7Cr 6.55Cr 273.84Cr
Net income - -
Net Debt -1.84TCr -1.37Cr -1.18Cr -1.12Cr -1.02Cr -1.9Cr -131.14Cr -1.91Cr -13Cr -5.11Cr -67Cr -5.16Cr -5.04Cr -210.82Cr -1.84TCr -1.37Cr -1.18Cr -1.12Cr -1.02Cr -1.9Cr -131.14Cr -1.91Cr -13Cr -5.11Cr -67Cr -5.16Cr -5.04Cr -210.82Cr
Logo Curiosis, Inc.
Curiosis Inc is a Korea-based company principally engaged in the development and manufacture of bioresearch equipment, lab automation products, and medical devices. The Company is mainly engaged in the development and manufacture of bio research equipment for implementing lab automation based on bioengineering and automation control technologies, such as automated live-cell imaging systems. Additionally, the Company is engaged in the development and manufacture of lab automation systems including colony picking systems, digital pathology scanners, as well as automated cell concentration and separation systems. The Company is engaged in the manufacture and sales of cell counters and aesthetic medical devices as well.
Employees
-
Date Price Change Volume
14/26/14 7,820.00 -6.12% 1,42,019
11/26/11 ₩8,330.00 +0.12% 1,19,002
10/26/10 ₩8,320.00 -0.60% 65,690
09/26/09 ₩8,370.00 +1.33% 53,628
08/26/08 ₩8,260.00 -5.71% 1,12,262
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A494120 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!